Corporate News & RNS

2022

09 August

Bispecific designs patent application

28 July

Appointment of Chief Executive Officer

06 May

Trading update

01 April

Block admission six monthly return

14 March

Update on Board changes

28 February

Director changes

21 February

Director change

10 February

Statement re: movement in share price

14 January

Formation of New Scientific Advisory Panel

11 January

Holding(s) in Company

Sign up for Investor Alerts

Investor Alert

Sign up for Investor Alerts »

Read more about us

Fusion Antibodies Company Profile

Read More »

View Investor Videos

Investor Videos

Watch latest video »